{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:19:22Z","timestamp":1773278362934,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.juro.2010.03.134","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T08:41:40Z","timestamp":1276850500000},"page":"464-469","source":"Crossref","is-referenced-by-count":34,"title":["Clinical Outcome of Primary Versus Secondary Bladder Carcinoma In Situ"],"prefix":"10.1097","volume":"184","author":[{"given":"Daher C.","family":"Chade","sequence":"first","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Adamy","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard H.","family":"Bochner","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Machele","family":"Donat","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry W.","family":"Herr","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Dalbagni","sequence":"additional","affiliation":[{"name":"Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2010.03.134_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-5347(17)68193-X","article-title":"Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy","volume":"68","author":"Melicow","year":"1952","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.03.134_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0094-0143(21)00780-1","article-title":"Carcinoma in situ of the urinary tract","volume":"11","author":"Utz","year":"1984","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.juro.2010.03.134_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2005.06.135","article-title":"High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder","volume":"66","author":"Sylvester","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.03.134_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0094-0143(21)00139-7","article-title":"Carcinoma in situ: comments on the pathobiology of a paradox","volume":"7","author":"Weinstein","year":"1980","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.juro.2010.03.134_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.6004\/jnccn.2009.0004","article-title":"Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis","volume":"7","author":"Nese","year":"2009","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.juro.2010.03.134_bib6","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/ijc.24619","article-title":"Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development","volume":"125","author":"Zieger","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2010.03.134_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0022-5347(01)67650-X","article-title":"Carcinoma in situ of the bladder","volume":"153","author":"Hudson","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.03.134_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.urolonc.2007.12.011","article-title":"The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Guerin immunotherapy","volume":"27","author":"Gofrit","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2010.03.134_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/00365590410028692","article-title":"Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-Guerin","volume":"38","author":"Andius","year":"2004","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.juro.2010.03.134_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2003.09.013","article-title":"Bladder carcinoma in situ in 2003: state of the art","volume":"45","author":"Witjes","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.03.134_bib11","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1100\/tsw.2006.404","article-title":"Natural history, recurrence, and progression in superficial bladder cancer","volume":"6","author":"Sylvester","year":"2006","journal-title":"Sci World J"},{"key":"10.1016\/j.juro.2010.03.134_bib12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0046-8177(99)90153-3","article-title":"The \u201cWHO\/ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms\u201d: continued discussion","volume":"30","author":"Reuter","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.juro.2010.03.134_bib13","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/cncr.1980.45.s7.1842","article-title":"Carcinoma in situ of the bladder","volume":"45","author":"Utz","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2010.03.134_bib14","first-page":"2794","article-title":"Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder","volume":"37","author":"Farrow","year":"1977","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2010.03.134_bib15","first-page":"499","article-title":"Carcinoma in situ","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.juro.2010.03.134_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-5347(17)58916-8","article-title":"Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ","volume":"116","author":"Althausen","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.03.134_bib17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.03.134_bib18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1097-0142(19830801)52:3<524::AID-CNCR2820520324>3.0.CO;2-C","article-title":"Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms","volume":"52","author":"Prout","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2010.03.134_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/1097-0142(19940701)74:1<115::AID-CNCR2820740120>3.0.CO;2-R","article-title":"Carcinoma in situ of the urinary bladder","volume":"74","author":"Orozco","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2010.03.134_bib20","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","article-title":"Survival of patients with carcinoma in situ of the urinary bladder","volume":"85","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2010.03.134_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1442-2042.2008.02012.x","article-title":"Clinical outcomes of bacillus Calmette-Guerin instillation therapy for carcinoma in situ of urinary bladder","volume":"15","author":"Takenaka","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.juro.2010.03.134_bib22","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","article-title":"Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?","volume":"166","author":"Herr","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.03.134_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eururo.2007.06.030","article-title":"Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?","volume":"53","author":"Denzinger","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.03.134_bib24","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.03.134_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2007.03.024","article-title":"Age and outcome of superficial bladder cancer treated with bacille Calmette-Guerin therapy","volume":"70","author":"Herr","year":"2007","journal-title":"Urology"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710032611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710032611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.03.134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:46:15Z","timestamp":1651196775000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.03.134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1016\/j.juro.2010.03.134"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.03.134","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}